
Quali-Care Pharmaceuticals Limited
About Quali-Care Pharmaceuticals Limited
Data last updated:
Quali-Care Pharmaceuticals Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 November 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG1985PLC005955. The company has 3 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹62 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Lakshmi Narasimha Rao Chandana and Anand Kumar Veerapaneni.
Its last annual general meeting (AGM) was held on 30 September 2013, and its latest financial statements are for the year ended 31 March 2013. The registered office is at G – 8 Emeraldamrutha Hills Panjagutta, Hyderabad, Telangana, India.
As per MCA filings, the company has open charges of ₹1.71 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 1 case is pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
CIN history
Quali-Care Pharmaceuticals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239TG1985PLC005955, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG1985PLC005955 | Current |
| U24239AP1985PLC005955 | Previous |
| U24239AP1985PTC005955 | Previous |
Contact details
Quali-Care Pharmaceuticals Limited's registered office is in Hyderabad, Telangana.
- Registered AddressG – 8 Emeraldamrutha Hills Panjagutta, Hyderabad, Telangana, India
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Quali-Care Pharmaceuticals Limited
FY 2013 filings availableFinancial Statement Summary
| Metrics | FY 2012-13 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2012-13 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Quali-Care Pharmaceuticals Limited, buy the company report.
Board of directors of Quali-Care Pharmaceuticals Limited
Quali-Care Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anand Kumar Veerapaneni Also directs: Savan Pharmaceuticals Private Limited | Additional Director | 24 Oct 2016 | 10 Years 0 Months | Current |
| Lakshmi Narasimha Rao Chandana | Director | 20 Apr 2013 | 13 Years 6 Months | Current |
| Surya Bhaskaramma Veerapaneni Also directs: Savan Pharmaceuticals Private Limited | Additional Director | 30 Jan 2010 | 16 Years 9 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Jul 2013 | 10439275 | Punjab National Bank | ₹75 Lakh | Open | |
| 01 Nov 2004 | 90136369 | Manasa Co - Op. Urban Bank Ltd. | ₹30 Lakh | Open | |
| 30 Sep 1997 | 90135714 | Ceat Financial Services Ltd. | ₹1.93 Lakh | Open | |
| 19 Mar 1997 | 90135659 | State Bank of Hyderabad | ₹10.8 Lakh | Open | |
| 19 Sep 1996 | 90135611 | State Bank of Hyderabad | ₹25 Lakh | Open |
Total charge records: 7 View all charges
Legal cases
Quali-Care Pharmaceuticals Limited has 3 court cases on record: 2 filed by Quali-Care Pharmaceuticals, 1 filed against it. 1 case is pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 1 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Writ petition | Filed against the company | Pending |
| High Court of Uttarakhand | Court case (WPMS) | Filed by the company against State and Others | Disposed |
| High Court of Uttarakhand | Court case (WPMB) | Filed by the company against State and Others | Disposed |
To see the full case history of Quali-Care Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Quali-Care Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Quali-Care Pharmaceuticals has 3 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Quali-Care Pharmaceuticals Limited, buy the company report.
Recent activity
Quali-Care Pharmaceuticals Limited has 9 board changes on record since 2010: 3 appointments and 6 cessations. The latest: Sravan Veerapaneni ceased to be Director on 26 Oct 2016.
7 earlier events are in the company report.
Frequently asked questions
Quali-Care Pharmaceuticals is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 November 1985 (41+ years old) and is registered under CIN U24239TG1985PLC005955.
Quali-Care Pharmaceuticals has 3 current directors:
- Anand Kumar Veerapaneni - Additional Director
- Lakshmi Narasimha Rao Chandana - Director
- Surya Bhaskaramma Veerapaneni - Additional Director
The latest financial statements of Quali-Care Pharmaceuticals on record with the MCA are for the year ended 31 March 2013. Its last annual general meeting was held on 30 September 2013. Year-wise statements from 2015 are in the company report.
No. Quali-Care Pharmaceuticals has 3 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Quali-Care Pharmaceuticals is U24239TG1985PLC005955. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Quali-Care Pharmaceuticals has 3 court cases on record: 2 filed by the company and 1 filed against it. 1 is pending.
Quali-Care Pharmaceuticals was incorporated on 18 November 1985, making it 41+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sravan Veerapaneni ceased to be Director on 26 Oct 2016. Anand Kumar Veerapaneni was appointed as Additional Director on 24 Oct 2016. Lakshmi Narasimha Rao Chandana ceased to be Additional Director on 30 Sep 2013. Quali-Care Pharmaceuticals has 9 board changes on record in total.
The registered office of Quali-Care Pharmaceuticals is at G – 8 Emeraldamrutha Hills Panjagutta, Hyderabad, Telangana, India.
Quali-Care Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

